title: Ifosfamide-induced Fanconi syndrome and desmopressin-responsive nephrogenic diabetes insipidus.
authors.forename: Sophia C
authors.initials: SC
authors.lastname: Kamran
authors.forename: William F
authors.initials: WF
authors.lastname: Pendergraft
authors.forename: David C
authors.initials: DC
authors.lastname: Harmon
authors.forename: Mario F
authors.initials: MF
authors.lastname: Rubin
mesh_terms: D000281:Administration, Intranasal; D000328:Adult; D050034:Antidiuretic Agents / Q000008:administration & dosage*; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects*; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage*; D018500:Diabetes Insipidus, Nephrogenic / Q000175:diagnosis / Q000188:drug therapy*; D005198:Fanconi Syndrome / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000009:adverse effects*; D011141:Polyuria / Q000209:etiology
chemical_list: D050034:Antidiuretic Agents; D018906:Antineoplastic Agents, Alkylating; D003894:Deamino Arginine Vasopressin; D007069:Ifosfamide